Stem-cell transplantation in patients with germ cell tumors

被引：0
|
作者：
Linkesch, W [1 ]
机构：
[1] Graz Univ, Med Klin, Klin Abt Hamatol, A-8036 Graz, Austria
来源：
ACTA MEDICA AUSTRIACA | 2000年 / 27卷
关键词：
germ cell tumor; stem-cell transplantation; high-dose chemotherapy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
High dose chemotherapy (HDCT) with autologous stem cell transplantation in patients with relapsed or refractory non-seminomatous germ cell tumors seems to be the only therapeutic option with curative intention. Evaluation of a scored risk profile before HDCT might significantly support the precise estimation of results after HDCT. Patients with a negative or low score could achieve long-lasting complete remissions or might be cured, whereas patients with absolutely refractory disease do not benefit from HDCT. Ongoing prospective randomised trials in Europe and USA comparing standardtherapy with KDCT will hopefully contribute to the right therapeutic decision in the future.
引用
收藏
页码：30 / 32
页数：3
相关论文
共 50 条
  • [31] Radioimmunotherapy and stem-cell transplantation in the treatment of aggressive B-cell lymphoma
    Shimoni, Avichai
    Nagler, Arnon
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2110 - 2120
  • [32] Management of Germ Cell Tumors in Pediatric Patients
    Weil, Brent R.
    Billmire, Deborah F.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 30 (02) : 325 - 338
  • [33] Targeted therapies for patients with germ cell tumors
    Fennerf, Martin H.
    Beutel, Gernot
    Gruenwald, Viktor
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (04) : 511 - 522
  • [34] High dose chemotherapy followed by autologous hematopoietic stem cell transplantation for advanced germ cell tumors: State of the art and a single-center experience
    Pierantoni, Francesco
    Maruzzo, Marco
    Bimbatti, Davide
    Finotto, Silvia
    Marino, Dario
    Galiano, Antonella
    Basso, Umberto
    Zagonel, Vittorina
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 169
  • [35] Stable hematopoietic recovery after peripheral blood stem cell transplantation in patients receiving high-dose chemotherapy for advanced germ cell tumors
    Kumano, Masafumi
    Miyake, Hideaki
    Hara, Isao
    Furukawa, Junya
    Takenaka, Atsushi
    Fujisawa, Masato
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4965 - 4968
  • [36] Stem cell transplantation in pediatric solid tumors
    Lang, Peter
    Schlegel, Paul-Gerhardt
    ONKOLOGE, 2021, 27 (05): : 464 - 469
  • [37] Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors
    Nieto, Y.
    Tu, S. -M.
    Bassett, R.
    Jones, R. B.
    Gulbis, A. M.
    Tannir, N.
    Kingham, A.
    Ledesma, C.
    Margolin, K.
    Holmberg, L.
    Champlin, R.
    Pagliaro, L.
    ANNALS OF ONCOLOGY, 2015, 26 (10) : 2125 - 2132
  • [38] Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation
    Agrawal, Vaibhav
    Abonour, Rafat
    Abu Zaid, Mohammad
    Althouse, Sandra K.
    Ashkar, Ryan
    Albany, Costantine
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    CANCER, 2021, 127 (20) : 3751 - 3760
  • [39] Update on testicular germ cell tumors
    Mannuel, Heather D.
    Mitikiri, Nirupama
    Hussain, Arif
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (03) : 265 - 270
  • [40] Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors
    Hara, I
    Yamada, Y
    Miyake, H
    Nomi, M
    Hara, S
    Yamanaka, K
    Takechi, Y
    Oka, Y
    Nakamura, I
    Gotoh, A
    Gohji, K
    Arakawa, S
    Kamidono, S
    ANTI-CANCER DRUGS, 1999, 10 (08) : 711 - 718
12345